PART 2: Dr. Robert Malone on Ivermectin, Escape Mutants, and the Faulty Logic of Vaccine Mandates
In part one of this American Thought Leaders episode, mRNA vaccine inventor Dr. Robert Malone explained the latest research on COVID-19 vaccines, booster shots, and natural immunity.
Now in part two, we take a closer look at repurposed drugs like ivermectin and how a universal vaccination policy could actually backfire—and bring about the emergence of vaccine-resistant escape mutants.
At their core, vaccine mandates are not just unethical and divisive, but also “impractical and unnecessary,” says Dr. Malone.
Below is a list of references mentioned or related to the discussion in this episode:
“Ivermectin for preventing and treating COVID-19” — The Cochrane Database of Systematic Reviews
“Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19” — American Journal of Therapeutics
“Dexamethasone in Hospitalized Patients with Covid-19” — The New England Journal of Medicine
The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines (Note: This is a preprint)
“Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants” — The New England Journal of Medicine
“The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines” (Note: This is a preprint)
“New delta variant studies show the pandemic is far from over” — ScienceNews
“Read: Internal CDC document on breakthrough infections” — The Washington Post
“Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections” (Note: This is a preprint)
“SARS-CoV-2 variants of concern and variants under investigation in England” — Public Health England
“Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting” — The New England Journal of Medicine
“Real-World Study Captures Risk of Myocarditis With Pfizer Vax” — MedPage Today
CDC: “Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020—August 2021”
“Causes and consequences of purifying selection on SARS-CoV-2” — Genome Biology and Evolution
“The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus” — Journal of Travel Medicine
Subscribe to the American Thought Leaders newsletter so you never miss an episode.